Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar-13 and Pneumo-23 in COPD and Asthma
NCT02787863Phase 4Completed
- Start
- Sep 2012
- Primary completion
- Dec 2016
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Prevnar 13 and ProDiax-23 in pneumococcal infection. Started Sep 2012; status: completed.
02
Drugs
Prevnar 13ProDiax-23
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02787863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787863.